Multiple Sclerosis Drugs Market Outlook 2024-2028, 2033 - A $48 Billion Global Opportunity Dominated by Biogen, Novartis, Roche, Bayer HealthCare, and Pfizer
16 mai 2024 08h00 HE
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global multiple sclerosis drugs...
Multiple Sclerosis (MS) Market to Cross USD 28.21 Billion by 2030 due to Rising Prevalence of Multiple Sclerosis (MS) and Favorable Reimbursement Policies | Research by SNS Insider
10 mai 2023 09h15 HE
|
SNS Insider pvt ltd
Pune, May 10, 2023 (GLOBE NEWSWIRE) -- “The Multiple Sclerosis (MS) Market was valued at USD 23.2 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 2.2% over the...
Global Multiple Sclerosis Treatment Market Report 2023: Sector is Projected to Reach $38.41 Million in 2031 at a CAGR of 4.3%
03 mai 2023 10h53 HE
|
Research and Markets
Dublin, May 03, 2023 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.The global...
Multiple Sclerosis Treatment Market Size to Surpass USD 30.55 Billion by 2030 at 2.31% CAGR – Report by Market Research Future (MRFR)
15 févr. 2023 09h00 HE
|
Market Research Future
New York, USA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Multiple Sclerosis Treatment Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Multiple Sclerosis...
Global Multiple Sclerosis Industry Review 2018-2020 with Forecasts to 2026 - Market Size by Country, Competitor Drug Sales, Market Shares, and More
24 déc. 2021 06h58 HE
|
Research and Markets
Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
Worldwide Multiple Sclerosis Therapeutics Industry to 2027 - by Drug Class, Route of Administration, and Distribution Channel and Geography
14 avr. 2021 05h08 HE
|
Research and Markets
Dublin, April 14, 2021 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Drug Class, Route of Administration, and Distribution...
Multiple Sclerosis Market: 2020 Drivers, Restraints, Drug Class, Diagnosis, End-Users, Distribution Channel, Industry SWOT Analysis and Company Profiles Opexa Therapeutics, Inc, Actelion Pharmaceuticals Ltd
07 mai 2020 06h29 HE
|
Data Bridge Market Research
WILMINGTON, N.C., May 07, 2020 (GLOBE NEWSWIRE) -- Multiple Sclerosis Market Size, Status and Forecast 2020-2027 its latest research report released by Data Bridge Market Research. The market report...